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Abstract
Background: Trichuriasis is a parasitic disease caused by the human whipworm, Trichuris trichiura. It affects millions
worldwide, particularly in the tropics. This nematode parasite burrows into the colonic epithelium resulting in
inflammation and morbidity, especially in children. Current treatment relies mainly on general anthelmintics such as
mebendazole but resistance to these drugs is increasingly problematic. Therefore, new treatments are urgently
required.
Methods: The prospect of using the retinoid X receptor (RXR) antagonist HX531 as a novel anthelmintic was
investigated by carrying out multiple viability assays with the mouse whipworm Trichuris muris.
Results: HX531 reduced both the motility and viability of T. muris at its L3, L4 and adult stages. Further, bioinformatic
analyses show that the T. muris genome possesses an RXR-like receptor, a possible target for HX531.
Conclusions: The study suggested that Trichuris-specific RXR antagonists may be a source of much-needed novel
anthelmintic candidates for the treatment of trichuriasis. The identification of an RXR-like sequence in the T. muris
genome also paves the way for further research based on this new anthelmintic lead compound.
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Background
Trichuris trichiura, the human whipworm, is an intestinal
nematode affecting over 450 million people worldwide,
particularly those living in the tropics [1]. T. trichiura bur-
rows into the epithelial lining of the colon to cause inflam-
mation, and in cases of high parasite burden can lead to
diarrhoea, poor growth, finger clubbing, anaemia and rec-
tal prolapse [2]. Other members of the Trichuris genus
can have damaging effects on livestock, decreasing
productivity and thus causing farming communities to
be trapped in a state of poverty. Currently, the only
treatment for trichuriasis is the distribution of anthel-
mintics, such as mebendazole. However, these drugs
only affect the adult stage of the parasite, and resist-
ance is becoming increasingly common; in some cases
mebendazole has been reported to be as low as 45%
effective [3]. Even when parasites are cleared from the
host, re-infection from the environment is common. There-
fore, there is an urgent medical need for new treatments
for this parasitic infection.
Nuclear hormone receptors such as the retinoid X re-
ceptor (RXR) play many vital roles in the development
of organisms [4]. Indeed, RXRα KO mice are not viable
[5]. In mammals, there are three isoforms of intracellular
RXR receptors (α, β and γ), and these function as hetero-
or homo-dimers [6]. Upon dimerisation, co-activator or
co-repressor molecules are recruited and the transcription
of genes under the control of these receptors is modified.
The natural ligand for RXR homodimers is 9-cis-retinoic
acid, however, since RXR can heterodimerise with other
nuclear hormone receptors such as the retinoic acid re-
ceptor (RAR), peroxisome proliferator-activated receptor
(PPAR) and vitamin D receptor (VDR), its ligands also
include all-trans-retinoic acid, fatty acids and vitamin D
[7,8].
Since RXR receptors are highly evolutionarily conserved
[9], it is not unreasonable to propose that parasites may
also have similar receptors. Indeed, the parasitic trematode
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Schistosoma mansoni has been shown to possess RXR-like
receptors [10]. In this parasite, a role for such receptors in
the expression of female genes has been proposed [10].
Retinoic acid may have several important functions in par-
asites. For example, Onchocerca volvulus secretes a protein
which sequesters retinoic acid [11]. Also, the Ascaris suum
ABA-1 allergen has demonstrated retinol and retinoic
acid binding capabilities [12] and Brugia malayi has been
shown to take up radio-labelled retinoic acid [13]. Retinoic
acid is a ligand of RXR, therefore this may suggest import-
ant roles of RXR in parasitic species. This study tested
whether RXR is important in the biology of Trichuris
muris, the laboratory model parasite for human trichuriasis,
by investigating the actions of an RXR-active compound on
T. muris viability. T. muris is maintained in laboratory mice
by oral infection of embryonated eggs. Eggs hatch in the
large intestine and progress through four larval stages
before becoming fecund adults at around day 35 post-
infection [14].
Bioinformatic analysis of the T. muris genome [15] dem-
onstrated that T. muris possesses an RXR-like receptor.
Two synthetic retinoids known to modulate the function
of mammalian RXR were used to target worm viability
in vitro. HX630 is an RXR agonist which can bind to RXR
and also to nuclear hormone heterodimers, which include
RXR as a partner, thereby activating RXR signalling, in-
cluding RXR-RAR signalling [16,17]. Conversely, HX531 is
an antagonist of RXR and has been shown to inhibit both
RXR-RAR heterodimers and PPARγ-RXR heterodimers
in mammalian cells [18,19]. To our knowledge, neither
HX630 nor HX531 have been tested for anti-parasitic
activity. The blocking of the RXR receptor by HX531 re-
ported here results in reduced viability of the T. muris
parasite at L3, L4 and adult stages of its lifecycle. Three dif-
ferent assays were used to assess worm viability (motility
scoring, MTT assay and a novel camera-based method)
and their utility as a measure of worm health was com-
pared. The findings suggest that RXR may represent a
much-needed, novel drug target for the treatment of
trichuriasis.
Methods
Animals, parasites and compounds
Immunodeficient SCID mice were bred by the Biological
Services Facility (BSF, University of Manchester, UK). All
procedures carried out on animals were performed under
a Home Office licence approved by the University of
Manchester Ethical Review body, and complied, at all
times, with UK laws and regulations. Mice were housed
in sterile conditions and all experiments were carried out
in accordance with the UK Animals (Scientific Procedures)
Act 1986.
The T. muris (Edinburgh (E) strain) was maintained as
previously described by Wakelin [20]. For in vitro assays,
SCID mice were infected with approximately 200 infect-
ive T. muris eggs by oral gavage. At days 24, 31 and 40,
mice were sacrificed and the caecum and colon were
removed, opened longitudinally and washed in pre-
warmed 0.9% NaCl. Guts were incubated in 0.9% NaCl
at 37°C for 1 h. Parasites were isolated and 4 parasites
per well were transferred into a 96-well plate containing
100 μl fresh RPMI 1640 medium supplemented with
penicillin (500U/ml) and streptomycin (500 μg/ml). Com-
pounds of interest were added to make a final volume of
200 μl per well. Final concentrations of the compounds
were as follows: Mebendazole (Ovex) (McNeil, Berkshire,
UK) 200, 100 and 50 μg/ml; HX630 (RXR Agonist) and
HX531 (RXR Antagonist) (both kind gifts from Hiroykui
Kagechika, Tokyo Medical and Dental University, Japan)
100, 10 and 1 μM. HX630 and HX531 were dissolved in
0.2% DMSO, and therefore the vehicle treatment consisted
of 0.2% DMSO without any active drug. Bleach (5%) was
used as a positive control. Negative control wells con-
tained 200 μl RPMI 1640 media plus penicillin (500U/ml)
and streptomycin (500 μg/ml).
Motility assay
Following incubation with test compounds for 24 h, the
motility of T. muris larvae was assessed using an Olympus
SD-ILK microscope. A scale of 0–3 was used; 0 = dead,
1 = very low motility, 2 = low motility and 3 = normal
motility [21].
MTT assay
After 24 h incubation with the test compounds, worms
were transferred into 100 μl fresh RPMI 1640 medium
plus penicillin (500U/ml) and streptomycin (500 μg/ml).
100 μl MTT reagent (Thiazolyl blue tetrazolium bromide;
Sigma, Dorset, UK) was added to each well at a concen-
tration of 6 mg/ml in deionised water. The plate was
then incubated at 37°C, 5% CO2 for 1 h. The larvae
were transferred into a new 96 well plate containing
200 μl DMSO and again incubated at 37°C, 5% CO2 for
1 h to solubilise the formazan crystals. The worms were
removed and absorbance of formazan was measured at
a wavelength of 490 nm using a microplate reader
(Dynex Technologies, VA, USA).
Camera motility assay
Parasites were filmed recorded in 96 well plates for 200
frames at 10 frames per second using an Andor Neo
camera and LED array illumination. Parasite motility
was determined by an algorithm that thresholds the
movie based on variance in pixel intensity over time
and then counts motile pixels.
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Bioinformatics
Protein sequences from the T. muris gene set 2.1 (Feb
2013) were obtained from ftp.sanger.ac.uk/pub/pathogens/
Trichuris/muris/ and used to build a local BLAST database.
The human RXR alpha protein sequence was queried
against this database using blastp 2.2.29+. The most signifi-
cant four matches were aligned, using Clustal Omega,
against representatives of the RXR gene family and the
related NR2F gene family, and selected nematode genes
annotated as RXR homologues. The more distantly related
C. elegans protein NHR-49 was used as an out group. A
phylogenetic tree was constructed using the neighbour-
joining method.
Statistics
Statistical analyses were performed using the unpaired
t-test or one way ANOVA (with Tukey’s multiple compari-
son post-hoc test), as appropriate, with the statistical pack-
age GraphPad Prism (Version 6). A p value of less than
0.05 was considered significant.
Results
The T. muris genome contains an RXRα-like sequence
Given the availability of the T. muris genome, the con-
served nature of the RXR nuclear hormone receptor and
the knowledge that other parasitic nematodes have retinoic
acid binding capacity, the human RXRα protein sequence
was queried against the T. muris gene set 2.1 (Feb 2013).
The most significant four matches were aligned against
representatives of the RXR gene family, including genes
from other nematodes annotated as RXR homologues [22],
and representatives of the related NR2F gene family. The
more distantly related C. elegans protein NHR-49 was
used as an outgroup. Figure 1A is a neighbour joining
tree showing the relationship between these sequences.
T. muris appears to have a single orthologue of the
RXR genes [TMUE:s0189001000], which encodes a pro-
tein that is 55% identical to human RXRα.
To support the hypothesis that this gene encodes a
functional receptor, sequence conservation was analysed
more closely. Key residues in the DNA-binding domain,
including both zinc fingers and the P-box and T-box
sequences [23] are conserved between human RXR and
T. muris sequences (Figure 1B). Residues in the ligand-
binding domain known to be important for functionality
of nuclear hormone receptors [24] are also conserved
(Figure 1C). Whilst this does not demonstrate that
T. muris TMUE_s0189001000 acts functionally as a
retinoid X receptor, is does suggest that it is a functional
nuclear hormone receptor and is closely related to the
RXR family. Furthermore, homologues of this receptor are
found in other parasitic nematodes (Figure 1A), suggesting
RXR-active compounds have the potential to interfere
with parasite biology.
The RXR antagonist HX531 reduced the viability of L3/L4
T. muris in vitro
To assess whether the RXR antagonist HX531 affects the
viability of the L3 and L4 stages of the T. muris parasite,
larvae were extracted from infected mice at day 24 post
infection, a time point when both L3 and early-moulted
L4 larvae are present. Larvae were incubated with HX531
at concentrations of 100, 10 and 1 μM for 24 h. As con-
trols, parasites were also incubated with the anthelmintic
mebendazole (200, 100 and 50 μg/ml), RXR agonist
(HX630; 100, 10 and 1 μM), vehicle, media only or bleach
(1:100). When incubated with mebendazole (200 μg/ml) or
bleach, both larval stages had a significantly reduced motil-
ity score compared to media-only controls (p < 0.01 and
p < 0.001, respectively) (Figure 2A). Interestingly, HX531
(100 μM)-treated larvae also had a significantly reduced
motility score compared to vehicle treatment (p < 0.001)
(Figure 2A), as well as reduced viability shown by the
MTT assay data (p < 0.05) (Figure 2B). Worm motility was
also assessed using a camera which tracked the movement
of the worm followed by measuring changing pixels in a
frame-by-frame analysis. Using this assay, L3-L4T. muris
larvae incubated with mebendazole (200 μg/ml) or bleach
again had significantly reduced motility compared to
media-only controls (p < 0.001 for both) (Figure 2C and D).
However, both the RXR antagonist (100 μM)-treated larvae
and RXR agonist (100 μM)-treated larvae showed a signifi-
cantly reduced motility compared to vehicle treatment
(p < 0.05 for both) (Figure 2C and D).
The RXR antagonist HX531 reduced the viability of L4 and
adult T. muris, in vitro
L4-adult T. muris were recovered at day 31 post-infection,
a time point when both newly moulted adults are present
but some worms still remain as L4. Incubation with bleach
significantly reduced motility scores compared to media-
only controls (p < 0.01 for both) (Figure 3A). Again, RXR
antagonist treatment (100 μM) resulted in significantly
reduced motility scores compared to vehicle controls
(p < 0.001) (Figure 3A). Using the motility score assay,
neither mebendazole nor the RXR agonist had any ef-
fect on parasite viability (Figure 3A). MTT assay data
showed that RXR antagonist treatment at both 100 μM
and 10 μM significantly reduced viability compared to
vehicle-treated controls (p < 0.05 for both) (Figure 3B).
None of the other treatments had any significant effect
on parasite viability compared to controls in the MTT
assay (Figure 3B). Camera analysis of worm movement
showed a reduced motility in parasites incubated with
bleach, compared to media only controls (p < 0.001 for
all) (Figure 3C and D). RXR antagonist treatment also
caused a significant reduction in movement compared
to vehicle controls at all three concentrations tested
(100, 10 and 1 μM) (p < 0.001 for all) (Figure 3C and D).
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Mebendazole and RXR agonist-treatment had no signifi-
cant effect on worm motility using this analysis (Figure 3C
and D).
The RXR antagonist HX531 reduced the viability of adult
T. muris, in vitro
To confirm the effects of RXR compounds on adult T. muris
alone, worms were extracted at day 40 post-infection a time
at which all worms present are mature adults. The adult
parasites had a reduced motility score when incubated with
bleach compared to media only controls (p < 0.001)
(Figure 4A). None of the other treatments had a significant
effect on T. muris motility scores (Figure 4A). However, the
MTT assay revealed a decreased parasite viability with
RXR antagonist treatment (100 μM), as well as the
bleach, when compared to vehicle controls (p < 0.05
for both) (Figure 4B). Mebendazole or RXR agonist
treatment showed no significant impact on worm vi-
tality at any of the concentrations tested, using the
MTT assay (Figure 4B). However, the camera-based
analysis of worm movement showed that mebendazole
(200 μg/ml) as well as bleach reduced worm motility
compared to media only controls (p < 0.01 for both)
(Figure 4C and D). RXR antagonist (100 μM) treat-
ment also caused a significant attenuation of worm




Figure 1 Neighbour-joining tree of T. muris homologues of RXR proteins. (A) The human RXRα protein sequence was queried against the
T. muris gene set 2.1 (Feb 2013). The most significant four matches were aligned against representatives of the RXR gene family, (including sequences
from other nematodes annotated as RXR homologues) and representatives of the related NR2F gene family. The more distantly related C. elegans
protein NHR-49 was used as an outgroup. The phylogenetic tree shows that T. muris has a single orthologue of the RXR proteins, TMUE_s0189001000.
(B) Alignment showing conservation of the DNA-binding domain. (C) Alignment showing conservation within the ligand-binding domain.
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although this was also observed with RXR agonist
(100 μM) treatment (p < 0.05) (Figure 4C and D).
Overall, the RXR antagonist HX531 emerges as a candi-
date lead compound for a novel anthelmintic, acting on
both larval and adult stages of the parasite. Its anti-parasitic
activity was detected using three different vitality assays for
worms recovered at day 21 (L3/L4) and day 31 (L4/adult)
and two out of three assays for the day 40 mature adult
stage parasites.
Discussion
Gastrointestinal helminth infections affect over 1 billion
people worldwide and are a significant cause of human
and livestock morbidity. With resistance to current treat-
ments becoming increasingly problematic and with the
lack of any vaccine, novel anthelmintics are urgently re-
quired [3]. In this study, it was demonstrated for the first
time that RXR antagonists show anthelmintic activity and
may therefore serve as important lead compounds in the
search for new treatments for nematode infections. At L3,
L4 and adult stages of the parasite, the human RXR
antagonist HX531 was able to reduce both the motility
and viability of T. muris larvae in vitro, as determined by a
range of viability assays. The RXR agonist HX630 also re-
duced worm motility in the L3/L4 and mature adult only
stages, however this was only observed in one viability
assay. Earlier work has demonstrated that synthetic
retinoids that are weak RAR agonists are able to inter-
fere with the development of filarial nematodes in vitro
[25,26]. Our studies of an RXR agonist and antagonist
in three different parasite viability assays, show that the
RXR antagonist (HX531) displays the most robust an-
thelmintic properties.
RXR is a nuclear hormone receptor which can hetero-
dimerise with many different partners, such as the vitamin
D receptor (VDR) or retinoic acid receptor (RAR). Owing
Figure 2 The RXR antagonist HX531 reduced the viability of L3/L4 T. muris in vitro. Worms were extracted from mice at day 24 post-infection
and incubated for 24 hours with vehicle, the anthelmintic mebendazole, the RXR agonist HX630, the RXR antagonist HX531 or bleach. Worm viability
was assessed using (A) a motility score, in which 0 = dead, 1 = very low motility, 2 = low motility and 3 = normal motility, or (B) MTT assay. An Andor
camera was used to capture the movement of T. muris by filming for 20s. Pixel changes from frame to frame were captured as an indicator or motility
(C) and quantified using Matlab software (D). Data are representative of two independent experiments (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001,
compared to controls, unless denoted otherwise.
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to its promiscuous nature, RXR is responsible for control-
ling the transcription of a variety of different genes and
therefore has a wide range of physiological effects, includ-
ing those essential for homeostasis and development. For
example, the human RXR controls fundamental biological
processes from reproduction to embryonic development
to cell proliferation [8,27]. Thus, it is not surprising that
disruption of the RXR signalling pathway could have a
detrimental effect on organism viability. An RXR-like re-
ceptor has been shown to exist in the trematode parasite
Schistosoma mansoni. Studies have shown that the SmRXR
is expressed constitutively and therefore may have many
roles throughout the parasite’s lifecycle [28]. The find-
ings in this investigation are in accord with this, as RXR
antagonism was able to reduce T. muris viability at three
different lifecycle stages; L3, L4 and adults.
The study demonstrated, for the first time, that T. muris
has an RXR-like sequence in its genome. This is important
not only in terms of novel drug targets, but also in the
context of helminth biology. The presence of this re-
ceptor indicated that ligands for RXR may be important
in Trichuris health. Current understanding of T. muris feed-
ing processes are limited. It is thought that the stichosome
gland cells release enzymes which break-down food
externally and then nutrients are taken up by bacillary
cells [29,30]. If RXR is important for T. muris health,
these nutrients might include those that act through
RXR signalling, such as retinoic acid or vitamin D.
Figure 3 The RXR antagonist HX531 reduced the viability of L4/adult T. muris in vitro. Worms were extracted from mice at day 31
post-infection and incubated for 24 hours with vehicle, the anthelmintics mebendazole and pyrantel embonate, the RXR agonist HX630, the
RXR antagonist HX531 or bleach. Worm viability was assessed using (A) a motility score, in which 0 = dead, 1 = very low motility, 2 = low
motility and 3 = normal motility, or (B) MTT assay. An Andor camera was used to capture the movement of T. muris by filming for 20s. Pixel
changes from frame to frame were captured as an indicator or motility (C) and quantified using Matlab software (D). Data are representative
of two independent experiments. (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001, compared to controls, unless denoted otherwise.
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The use of vitamin A to treat nematode infections is
controversial. A study has shown that vitamin A supple-
mentation to Ascaris-infected individuals can promote
worm-clearing Th2 responses [31]. In contrast, we have
previously reported that activation of the vitamin A
receptor, RAR, can cause increased inflammation in the
host during T. muris infection [32]. Remarkably, vitamin
A deficiency is associated with an increased ability to
control T. muris infections via innate lymphoid cell type
2 dependent immunity [33]. The data presented in the
current paper suggest that exploring the impact of
vitamin A or its metabolite retinoic acid on the nema-
tode itself as well as on its host responses is of consider-
able interest.
This study showed that the half-maximal inhibitory
concentration for HX531 on T. muris viability was be-
tween 10 μM and 100 μM. This was higher than 0.29 μM-
the reported IC50 of HX531 in mammalian kidney cells
[34]. This difference in potency may reflect the variations
in RXR sequence between mammals and parasites. Bio-
informatic analysis of the T. muris genome revealed that
this parasite has a sequence with 55% homology with
the human RXRα nuclear hormone receptor. Ideally
anti-parasitic drugs should affect the parasite and not
the host. For example, mebendazole binds to nematode
β-tubulin to prevent transport of secretory vesicles [35].
However, a current, widely-used anthelmintic, ivermectin,
has recently been identified as a novel FXR ligand [36] in
additions to its actions on glutamate-gated chloride
channels [37]. FXR is a nuclear hormone receptor
which heterodimerises with RXR and thus this sup-
ports the principle of targeting nuclear hormone re-
ceptors in the development of novel anthelmintics.
Looking to the future, the development of a novel
Figure 4 The RXR antagonist HX531 reduced the viability of adult T. muris in vitro. Worms were extracted from mice at day 40 post-infection
and incubated for 24 h with vehicle, the anthelmintics mebendazole and pyrantel embonate, the RXR agonist HX630, the RXR antagonist HX531 or
bleach. Worm viability was assessed using (A) a motility score, in which 0 = dead, 1 = very low motility, 2 = low motility and 3 = normal motility, or
(B) MTT assay. An Andor camera was used to capture the movement of T. muris by filming for 20s. Pixel changes from frame to frame were captured
as an indicator or motility (C) and quantified using Matlab software (D). Data are representative of two independent experiments. (n = 3).
*p < 0.05, **p < 0.01, ***p < 0.001, compared to controls, unless denoted otherwise.
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parasite-specific RXR antagonist remains a preferable
solution.
A number of nematode viability assays exist [21]. This
study used a novel technique for measuring nematode
vitality. An Andor camera was employed to video para-
site movement over a 10–20 s period, and Matlab soft-
ware was used to calculate the change in pixels resulting
from worm movement. Overall, this method gave results
consistent with the other viability assays, but provided
several advantages over other methods. This assay was
completely objective and did not require blinding. Re-
sults were reproducible between replicates and the speed
of this system advocates its use for high-throughput screen-
ing of test compounds to determine their anthelmintic
capacity. However, the camera motility assay also revealed
effects on T. muris after incubation with the RXR agonist.
Thus, this highlights the necessity of carrying out multiple
assays when testing drug effects on parasite vitality. The
techniques used here in showing an RXR antagonist to be a
candidate anthelmintic lead compound may gain further
traction as the T. muris genome [15] highlights additional,
druggable targets to pursue.
Conclusion
In conclusion, RXR antagonism may be a useful novel
method for treating trichuriasis, by reducing worm vitality
at different lifecycle stages. This study also showed, that
the T. muris genome has an RXR-like sequence, which
may open new doors in the understanding of Trichuris
biology.
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